Local
Local gay student blocked from making blood donation despite FDA easing policy
Red Cross acknowledges delays, study to examine further change

A gay D.C. native otherwise qualified to donate blood was denied that chance at a local hospital, demonstrating that obstacles remain after the FDA eased its ban on gay donations — even as the agency has set up a pilot study to assess lifting the blanket policy altogether.
Aubrey Lay, a 19-year-old student at the College of William & Mary, told the Washington Blade after the FDA eased its policy last month he registered with his family at Children’s National Hospital, a D.C.-based pediatrics center, in hopes of making a contribution under the belief he’d meet the new requirements.
“As a gay man, I was very excited that the FDA had relaxed its guideline restrictions on MSM donating blood, however imperfect this change may be,” Lay said. “This meant that for the first time since graduating high school, I would be able to donate blood.”
Lay said he would have been ineligible to donate under the former rule requiring 12 months of abstinence for gay men, but believed he would have been eligible under the new rules requiring only three months. Although the hospital’s website had the old information online, Lay said he proceeded to his appointment on April 29 under the “wishful thinking” the hospital would accept him.
But Lay was ultimately blocked from making a donation.
“It turned out I was giving them the benefit of the doubt where I shouldn’t have,” Lay said. “I signed in and had my intake interview during which I explained my sexual history, and that I had last had sexual contact in early January, over the three-month limit. After answering all these questions, I got my finger pricked and iron levels checked, and height, weight, [blood pressure] taken. Only then was I told that I would not be able to donate because the hospital’s policy has not yet caught up to national standards.”
Lay said he was “shaken” by the experience, having wanted to make a blood donation to help out as the nation battles the coronavirus crisis.
As evidence going to the hospital was a risk he didn’t take lightly, Lay said it was the first time he’d left his house in a month because he and his family took the Virginia stay-at-home order “very seriously.”
“I certainly would not have risked my own health, and that of others, had I known I would be turned away,” Lay said.
Amid the blood shortage during the coronavirus pandemic, the FDA last month announced it would ease the ban on blood donations for various groups, including men who have sex with men.
The earlier ban, established in 2015, required gay men to be abstinent for 12 months before making a donation, but the new policy eased those restrictions, requiring a deferral period of three months.
Before 2015, the FDA had a lifetime ban on blood donations from men who have had sex with men. The policy was implemented in 1983 at the height of the AIDS epidemic based on fears donations from gay men would allow HIV to enter the blood supply.
Lay, upon being denied the ability to donate blood, said he found the office of the hospital’s president next to the blood donation room and sought an audience.
The president, Lay said, apologized for the confusion and connected him with the doctor in charge of the blood bank. The doctor, Lay said, told him the hospital’s computer systems were interlaced with the new policy and — in normal times without coronavirus — it would take a month to disentangle them and make them consistent with the new policy.
The website for the Children’s National Hospital has been updated and no longer indicates it follows the earlier 12-month policy, but is in the process of making a transition to conform to the new guidance by June 2020.
A Children’s National Hospital spokesperson confirmed the center is still in the process of updating its policy for gay donors and expects resolution next month.
“We have the deepest appreciation for all our blood donors and see every day how their donation saves lives,” the spokesperson said. “We take every step to adhere to all regulations around blood donation and are working to update our policies, donor questionnaire and computer systems to align to the new FDA regulations. The FDA just approved the donor questionnaire for sites to use and we are hoping to have all policies in place in June. We encourage anyone who would like to donate to make an appointment and double check on the eligibility before coming in.”
Lay’s story isn’t unique as other gay men have reported being unable to donate blood after the FDA eased its ban. Whether or not each of these men expected to meet the requirements under the new deferral period of three months is unclear.
Gay TV personality Andy Cohen says he was denied the chance to donate, even though his plasma would be rich in the antibody for COVID-19. Lukus Estok, a young gay man who recovered from COVID-19, also told his story about being denied the opportunity to make a donation at the New York Blood Center. His Facebook post went viral on social media and was featured in a Good Morning America article.
Mathew Lasky, a spokesperson for the LGBTQ media watchdog GLAAD, which has been leading calls for a change in blood policy, said more and more stories are emerging of LGBTQ people being blocked from making donations despite the recent change.
“GLAAD is continuing to pressure the FDA to put science above stigma, and to remove any time-based deferral on gay and bisexual men, and others in the LGBTQ community, donating blood,” Lasky said. “In the meantime, it’s critical for individual blood centers to begin adhering to the new FDA guidelines as not to continue needlessly discriminating against LGBTQ people, and to address the critical blood supply shortages we’re seeing during COVID-19.”
The American Red Cross, which had called for the FDA to shorten its deferral period from the 12 months to three months before the new policy was implemented, cautioned via a spokesperson the implementation of updated rules “will take time.”
“As the largest blood provider in the country, we are working to implement the updated FDA eligibility changes and will provide an update on timeline in the near future,” the spokesperson said. “It’s important to note that the implementation process includes potentially thousands of individuals and involves complex system updates that do take time. We are working to develop a reinstatement process to share with potential donors in the near future.”
UPDATE: A Red Cross spokesperson after publication of this article told the Blade a June 1 target date has been set for full implementation of the FDA policy change.
“The American Red Cross is working to implement the updated FDA eligibility changes on June 1,” the spokesperson said. “We just want to emphasize that this process includes potentially thousands of individuals and involves system updates that will take time to implement.”
Even as blood centers work to update their system to conform to the new policy, LGBTQ advocates have said the change is insufficient and the FDA should scrap its deferral requirements entirely for men who have sex with men and instead implement a policy based on individual risk assessment. Such a policy could enable, for example, monogamous gay men or gay men with safe sex practices to make blood donations.
Among those calling for this change is California Attorney General Xavier Becerra, who last month led a letter to the Department of Health & Human Services with 19 other attorneys general urging the Trump administration to abandon the deferral period, citing the success of other countries, such as Spain, Italy and Portugal, that have implemented gender-neutral policies.
Many voices have emerged calling for any and all obstacles to gay men making blood donations being lifted because testing could determine whether a blood donation has HIV. Experts, however, say some caution is necessary as a window exists between donation and testing in which the test wouldn’t be able to determine if a donation was free of the virus.
Scott Schoettes, counsel and the HIV Project Director at Lambda Legal, articulated that warning in a conference call last month with reporters.
“People believe that it catches all new cases of HIV or new cases of Hepatitis B, Hepatitis C, other blood borne infections,” Schoettes said. “That is not the case. There is still a window period during which that testing would not uncover a newly acquired infection.”
But in a rare situation of hitting both the gas and brake at the same time amid a policy change, the FDA has indicated the agency also is in the early stages of a pilot program to determine whether or not the ban can be changed further in favor of a risk-based assessment.
Megan McSeveney, an FDA spokesperson, confirmed the agency is set to begin the study with “about 2,000 men who have sex with men and who would be willing to donate blood.”
“This study, being conducted at community health centers in key locations across the United States, could generate data that will help the FDA determine if a donor questionnaire based on individual risk assessment would be as effective as time-based deferrals in reducing the risk of HIV,” McSeveney said.
The Red Cross is participating in the efforts to ensure a new risk-based policy as opposed to a deferral period will keep the blood supply safe, a spokesperson for the non-profit said.
“We are very early in the study – we are currently finalizing the content of the new questions, and developing the specifics of the protocols, including site selection, which then will require government and ethical review board approval,” the spokesperson said. “The results of testing in combination with the responses to the questionnaire will be used to determine the value of the questions in interdicting new HIV infections.”
Based on the limited information of the study, there’s no indication a change will, in fact, follow eliminating the deferral period for gay men entirely in favor of a risk-based assessment.
Sarah Kate Ellis, CEO of GLAAD, said in a statement the pilot study was wholly necessary given medical experts who say any kind of deferral period is “stigma, not science.”
“During the current crisis, the FDA is wasting time and money on a pilot study when all the scientific research and medical authorities plainly state that gay and bi man should not be restricted from donating blood,” Ellis said. “All blood donations, regardless of sexual orientation, are screened to ensure healthy samples and now the American Medical Association, leading elected officials, and more than 600 medical professionals have all done the work for the FDA and unequivocally state that this ban needs to end.”
Lay, caught in the middle of reconsideration of the policy, said he awaits the day when the restrictions are changed so LGBTQ people can finally donate blood at a time when their help is needed.
“Because of this crisis, blood donation centers should not be turning people away at the door who are by all measures qualified donors, risking their health and the health of those around them by their very presence in these spaces,” Lay said. “It is so important that we make this discrepancy between policy and practice known so that we can push for more transparency in blood donation, and hopefully full implementation of the new policy, albeit imperfect.”
District of Columbia
Physician: addiction doesn’t always look the way you think it does
Yngvild Olsen headed HHS’s Center for Substance Abuse Treatment during Biden-Harris administration
Many people think the telltale signs of drug addiction include sweating and vomiting. But a prominent addiction medicine physician says the best signals aren’t always so visible.
Dr. Yngvild Olsen says more accurate signs come from the brain, specifically the compulsion to keep using drugs, including opioids, despite damage to education, career and relationships.
While it may be harder to understand the true nature of drug addiction, it’s never been more important because of the increased fatality risk of even microscopic amounts of fentanyl, which can be found in many illegal drugs.
Olsen, who headed the Center for Substance Abuse Treatment at the Department of Health and Human Services in the Biden-Harris administration, has worked in addiction treatment for more than two decades. She is now a healthcare advisor with the law and professional consulting firm Manatt, Phelps & Phillips and a physician at the Institute for Behavior Resources/Reach Health Services in Baltimore.
Olsen met with Youthcast Media Group to discuss her career, the opioid epidemic and what to know about fentanyl. The physician, a graduate of Harvard Medical School and the John Hopkins Bloomberg School of Public Health, cited her field experiences as key in shaping her perspective on addiction treatment and recovery. This interview is edited for clarity and length.
What made you believe this work in addiction treatment is important?
I had a couple of experiences really early on in my career that very significantly shaped my interest in addiction and addiction medicine, and my belief that I had a role, and that I could really help people get better from that disease. So the first was during the summer between my first and second year in medical school. I spent the summer on the Eagle Butte and Pine Ridge reservations in South Dakota and really saw firsthand just the devastating impact that substance use — in that case, alcohol — had on not only individuals, but their families and whole communities, and just how profound that impact had been for people who had lost their lives, who had lost family members, who had physically, emotionally and spiritually negative impacts of just feeling very hopeless and and trying to find solace in their substance use, particularly their alcohol use, and doing that without really finding it. I think that was really the lesson that experience taught me.
What did you learn about treatment practices during your medical education? How was that helpful to your career?
When I was a resident in general primary care at Boston Medical Center, I was really fortunate to have a group of mentors who also were general internists, like I was training to be, who were very interested and focused on medical education and research in substance use. And so they modeled for me many of the interactions that we had with patients. I got to do a research study with one of them looking at smoking cessation among people with opiate use disorder, taking methadone. And really importantly, I got to spend a month with one of them at the Boston City Public Health Department’s Opioid Treatment Program, or what some people call a methadone clinic, because he was their medical director. I got to see people recover, and who had recovered, who had gotten their lives back together, gotten their families back together, had new families (or) businesses. It was unbelievably helpful to see that people could recover, that they did recover, and that I, as a physician, could be part of their treatment. I saw people get better, and recover, with medications like methadone and buprenorphine, and other services designed individually for them. That was really helpful and kind of a big eye-opening moment for me.
What factors contribute to addiction and why is it considered a complex disease?
People come into treatment for their addiction — or when they’re not in treatment, but are in an emergency department or on the street — with a lot of shame. They have a lot of shame about this disease that they have, that for so long, they were told, ‘Well, you know, you should just stop. Why can’t you just stop?’ Well, we know that addiction is a disease. It’s a complex disease that has lots of different factors related to it. So there’s a big genetic component that combines with environmental factors and other risk factors. For example, people have what’s called adverse childhood experiences. Some of these are if they grow up with lots of physical or sexual abuse or emotional abuse or have parents who are in jail. That’s really traumatic and so all those childhood experiences that increase stress are a big risk factor.
What is the easiest opioid to get addicted to?
It used to be heroin. That was a big problem, particularly in the Northeast and other parts of the country. That shifted to prescription opioids, beginning around the year 2000. So for about 10 years, it was really prescription opioids that were a big problem — people misusing them. And then it switched back to heroin. And then in about 2015, fentanyl came on the scene, and that really changed the game, given just how unbelievably potent fentanyl is, so it doesn’t take a lot to cause an overdose. Now there are all those other synthetic opioids, like the orphines and nitazenes and all those combinations of other substances, but fentanyl is really what’s still kind of driving a really big part of the overdose crisis.
Do LGBTQ individuals face heightened challenges when battling addictions? How do addiction specialists like you account for those challenges?
We certainly know that the prevalence of overdose and the challenges of substances is higher in the LGBTQ+ community. Where I see patients, we did a big LGBTQ+ training and had a grant to specifically provide services to that population. Where we were located, in Baltimore City, there is a big transgender community not that far from us. Particularly in the LGBTQ+ population, they have multiple stigmas. So it just compounds multiple stressors. And stress is a risk factor for substance use, and particularly a risk factor for recurrence of a substance use disorder. And so when you have all these negative factors building up in people, that can make it that much more challenging for people to find the services that they find meaningful and that are welcoming and supportive of them. So we tried very hard — and we still do — to make sure that we are a welcoming and safe space, because I think it is that safety that is really paramount.
What advice would you give someone worried about a friend or family member’s substance use?
There are two things. One is: I would talk to that person about your concerns and how that person’s personality changes or their behavior changes when they’re using or in withdrawal, and how that might be impacting their health and how they’re feeling. And then second: you can let them know that there are actual treatments that are really helpful, that can make them feel better and that can help them get back to who they were before they started using. It’s important not to be accusatory because … [people] have a lot of shame already, and so when somebody starts accusing them, that shame just gets worse. And a lot of times, people who have a substance use disorder or are using opioids won’t necessarily agree that they have a problem when you first start to talk to them. But talk to them again every time something happens and say, ‘I’m really worried about you because this now has happened and I see it as being tied to your substance use.’ And let them know that there are people who can help and that they could actually feel a lot better.
This work is part of a partnership between the Washington Blade Foundation and Youthcast Media Group, funded in part through a FY26 Community Development Grant from the Office of D.C. Mayor Muriel Bowser. Adrian Malone is a senior at Bard High School Early College DC, one of Youthcast Media Group’s journalism class partners. Shreya Jyotishi, YMG assistant manager of content and programming, is a former Washington Blade intern and 2026 graduate of American University.
District of Columbia
Bet Mishpachah participates in D.C. Oct. 7 commemoration ceremony
Wednesday marked three years since Hamas attacked Israel
Bet Mishpachah Executive Director Joshua Maxey on Wednesday was among those who spoke at a ceremony in D.C. that marked the third anniversary of the Oct. 7 attack in Israel.
The Jewish Federation of Greater Washington hosted the ceremony that took place at the Washington Hebrew Congregation in Northwest D.C. Bet Mishpachah is the city’s LGBTQ synagogue.
“It was a deeply moving evening, especially hearing the stories of people who knew those who were murdered and those who survived and experiencing music that gave a voice to grief and hope,” Maxey told the Washington Blade.
Hamas militants on Oct. 7, 2023, killed roughly 1,200 people, including upwards of 360 partygoers at the Nova Music Festival near Re’im, a kibbutz that is a couple miles from the Gaza Strip, when it launched its surprise attack on Israel. The militants also kidnapped more than 200 people.
The Hamas-controlled Gaza Health Ministry says Israeli forces have killed more than 74,000 people in the enclave since Oct. 7.
The International Criminal Court in 2024 issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu; former Israeli Defense Minister Yoav Gallant; former Hamas leader Yahya Sinwar; Mohamed Diab Ibrahim al-Masri, the head of Hamas’s military wing known as the Qassam Brigades; and Ismail Haniyeh, chair of the Hamas Political Bureau, after it accused them of committing war crimes and crimes against humanity in Gaza and Israel.
The Israeli government has strongly denied it has committed genocide in Gaza.
An Israeli airstrike on a compound in Khan Younis, a city in southern Gaza, on July 13, 2024, killed killed Deif, one of the alleged Oct. 7 masterminds. Israel less than three weeks later assassinated Haniyah in Tehran, the Iranian capital. Israel Defense Forces soldiers on Oct. 16, 2024, killed Sinwar in Rafah, a city in southern Gaza.
Hamas last October released the remaining hostages in Gaza as part of a ceasefire agreement that President Donald Trump helped broker. Israel has continued to conduct airstrikes and other military operations in Gaza since the official suspension of hostilities took effect.
“For Bet Mishpachah, it was especially meaningful to lift up the names of LGBTQ+ people, those whose identities we know and those whose stories may never be fully known, who were murdered, and to honor the LGBTQ+ survivors whose resilience continues to inspire us,” said Maxey, referring to his participation in Wednesday’s ceremony. “Emily Damari’s story is particularly poignant: while held hostage, she had to hide the fact that she was gay because she feared that revealing her identity to her captors could put her life at even more risk. Yet, she survived.”
“Her story, like so many others, reminds us of the extraordinary courage it takes simply to remain human in the face of hatred,” he added. “May we continue to remember and to mourn, to honor, and to work toward a future rooted in peace and hope.”
Virginia
Campaign urges Virginia High School League to reverse stance on trans athletes
Equality Arlington and other advocacy groups behind ‘Right 2 Play’ VA’ initiative
Virginia advocacy groups have launched a campaign that urges the Virginia High School League to once again allow student athletes to compete on sports teams that correspond with their gender identity.
Equality Arlington on Sept. 16 published an article about the “Right 2 Play VA” campaign. Amy, a group representative, spoke about the initiative with the Washington Blade.
“The primary goal is to reverse the Virginia High School League’s discriminatory ban on allowing transgender girls to play on girls’ sports and replace it with a policy that is fair for all students.” they said.
The Virginia High School League in 2025 announced the policy, which reversed a previous position in support of transgender and nonbinary athletes. The 2025 policy coincided with President Donald Trump’s executive order — “Keeping Men Out of Women’s Sports” — that threatened to “rescind all funds from educational programs that deprive women and girls of fair athletic opportunities, which results in the endangerment, humiliation, and silencing of women and girls.”
The Arlington Gender Identity Alliance, Equality Virginia, and the American Civil Liberties Union of Virginia have also joined the “Right 2 Play VA” campaign.
“We had a policy in Virginia for 12 years that allowed transgender girls to play on girls’ sports teams, and we had not one instance — not one instance — that was brought forward demonstrating an unfair advantage or any type of safety concern,” said Amy.
Amy then discussed what they described are the benefits of trans youth playing sports.
“There are physical benefits. There are mental health benefits. There are community and social development benefits, and those are all well documented,” they said. “All kids should have the right to benefit from playing youth sports. We are talking about kids. We are talking about youth. We are not talking about Olympians. We are not talking about Division One college athletes. We are talking about kids in Virginia, and because the benefits of sports are so well documented, we think that every kid should have the ability to play sports.”
-
Central America5 days agoAlianza para la Inclusión fortalece la defensa de derechos LGBTQ en Centroamérica
-
Opinions5 days agoThe facts about Victory Fund’s investigation and the path forward
-
Georgia5 days agoIn Ga., 2 trans candidates believe voters are ready for them
-
Federal Government5 days agoBessent says Trump chose him for his qualifications, not his sexuality
